Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 945 entries
View as:

Advance Care Planning and Care Coordination for People With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05954013 Org: User:
Start: 08/06/20 End: 03/17/23 Due: 03/17/24

Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning

Phase: N/A Priority: Normal
NCT ID: NCT00184782 Org: User:
Start: 09/30/03 End: 12/31/08 Due: 12/31/09

Treatment of Anastomotic Leakage After Rectal Cancer Resection

Phase: N/A Priority: Normal
NCT ID: NCT04127734 Org: User:
Start: 04/01/20 End: 09/30/21 Due: 09/30/22

Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT04656392 Org: User:
Start: 04/20/21 End: 03/11/24 Due: 03/11/25

Carotid Artery Plaque Vulnerability Assessment Using Ultrafast Ultrasound Techniques

Phase: N/A Priority: Normal
NCT ID: NCT05218421 Org: User:
Start: 02/01/22 End: 11/01/23 Due: 11/01/24

QUEST: QUality of Life and Experiences of Sarcoma Trajectories

Phase: N/A Priority: Normal
NCT ID: NCT03441906 Org: User:
Start: 02/15/18 End: 02/28/21 Due: 02/28/22

Eplerenone, ACE Inhibition and Albuminuria

Phase: N/A Priority: Normal
NCT ID: NCT00315016 Org: User:
Start: 01/31/07 End: 07/31/11 Due: 07/31/12

Dose Tapering and Early Discontinuation to InCreAse cosT-effectIveness Of Immunotherapy for NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04909684 Org: User:
Start: 11/18/20 End: 11/30/24 Due: 11/30/25

A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study

Phase: N/A Priority: Normal
NCT ID: NCT05906316 Org: User:
Start: 07/01/23 End: 07/01/26 Due: 07/01/27

Social Robot Support for Healthcare Professionals

Phase: N/A Priority: Normal
NCT ID: NCT03857789 Org: User:
Start: 04/30/19 End: 02/28/20 Due: 02/28/21

The AOT (Acridine Orange and Taurolidine) Trial

Phase: N/A Priority: Normal
NCT ID: NCT00321165 Org: User:
Start: 06/30/06 End: 03/31/08 Due: 03/31/09

Dose Individualization of Pemetrexed - IMPROVE-III

Phase: N/A Priority: Normal
NCT ID: NCT03655834 Org: User:
Start: 02/01/19 End: 08/01/21 Due: 08/01/22

Mass-Drug Administration to Reduce Malaria Transmission

Phase: N/A Priority: Normal
NCT ID: NCT00509015 Org: User:
Start: 02/29/08 End: 08/31/08 Due: 08/31/09

Trajectory of Neuroinflammatory Markers in Cerebrospinal Fluid Prior to and After Thoracic Aortic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04523909 Org: User:
Start: 12/18/17 End: 12/01/26 Due: 12/01/27

Iohexol for Measuring Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT03946345 Org: User:
Start: 05/01/19 End: 04/30/21 Due: 04/30/22

Back-to-back Endoscopy Versus Single-pass Endoscopy and Chromoendoscopy in IBD Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT04291976 Org: User:
Start: 03/13/20 End: 11/07/23 Due: 11/07/24

Host-pathogen Interaction in Otitis Media

Phase: N/A Priority: Normal
NCT ID: NCT00847756 Org: User:
Start: 04/30/08 End: 07/31/11 Due: 07/31/12

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCA

Phase: N/A Priority: Normal
NCT ID: NCT05306184 Org: User:
Start: 01/01/22 End: 12/31/25 Due: 12/31/26

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03182296 Org: User:
Start: 11/10/16 End: 01/01/26 Due: 01/01/27

A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use

Phase: N/A Priority: Normal
NCT ID: NCT05783505 Org: User:
Start: 06/01/23 End: 10/01/26 Due: 10/01/27

Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT06546579 Org: User:
Start: 08/21/24 End: 06/30/25 Due: 06/30/26

The Effects of Mindfulness-based Cognitive Therapy in People With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05779137 Org: User:
Start: 04/17/23 End: 01/31/27 Due: 01/31/28

Virtual Reality Therapy for Pain Management at the Emergency Department

Phase: N/A Priority: Normal
NCT ID: NCT06089642 Org: User:
Start: 12/01/23 End: 04/01/25 Due: 04/01/26

The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04505761 Org: User:
Start: 08/01/20 End: 03/31/21 Due: 03/31/22

The Immunomodulatory Effects of Phlebotomy

Phase: N/A Priority: Normal
NCT ID: NCT02031614 Org: User:
Start: 01/31/14 End: 05/31/14 Due: 05/31/15